Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: Executive Summary. A Statement for Healthcare Professionals from the Neurocritical Care Society and the Society of Critical Care Medicine

Jennifer A. Frontera, John J. Lewin, Alejandro A. Rabinstein, Imo P. Aisiku, Anne W. Alexandrov, Aaron M. Cook, Gregory J. Del Zoppo, Monisha Kumar, Ellinor I.B. Peerschke, Michael F. Stiefel, Jeanne S. Teitelbaum, Katja E. Wartenberg, Cindy L. Zerfoss

Research output: Contribution to journalArticle

30 Scopus citations
Original languageEnglish (US)
Pages (from-to)2251-2257
Number of pages7
JournalCritical care medicine
Volume44
Issue number12
DOIs
StatePublished - Dec 1 2016

Keywords

  • anticoagulant
  • coagulopathy
  • guideline
  • intracranial hemorrhage
  • reversal

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Frontera, J. A., Lewin, J. J., Rabinstein, A. A., Aisiku, I. P., Alexandrov, A. W., Cook, A. M., Del Zoppo, G. J., Kumar, M., Peerschke, E. I. B., Stiefel, M. F., Teitelbaum, J. S., Wartenberg, K. E., & Zerfoss, C. L. (2016). Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: Executive Summary. A Statement for Healthcare Professionals from the Neurocritical Care Society and the Society of Critical Care Medicine. Critical care medicine, 44(12), 2251-2257. https://doi.org/10.1097/CCM.0000000000002057